JAMA Network
About The Study: In this cross-sectional study of data from January 2017 to December 2021, population-based screening and diagnosis remained below pre-pandemic levels for breast, cervical and colorectal cancer. The findings suggest that screening quickly rebounded after the initial stages of the pandemic; however, the longer follow-up time reveals that gaps in preventive cancer screening returned and worsened.
Authors: Allison H. Oakes, Ph.D., of Trilliant Health in Brentwood, Tennessee, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamaoncol.2022.5481)
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
